State Street’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

State Street’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-387,390	Closed	-$8.1M	–	3735
2016 Q3	$8.1M	Buy	387,390 +43,363	+13%	+$499K	﹤0.01%	2296
2016 Q2	$3.71M	Buy	344,027 +156,171	+83%	+$1.34M	﹤0.01%	2774
2016 Q1	$1.25M	Buy	187,856 +36,832	+24%	+$335K	﹤0.01%	3162
2015 Q4	$2.73M	Buy	151,024 +29,159	+24%	+$401K	﹤0.01%	2868
2015 Q3	$1.34M	Buy	121,865 +2,024	+2%	+$21.5K	﹤0.01%	3142
2015 Q2	$1.73M	Buy	119,841 +59,715	+99%	+$811K	﹤0.01%	3114
2015 Q1	$703K	Buy	60,126 +30,340	+102%	+$409K	﹤0.01%	3300
2014 Q4	$496K	Buy	+29,786	New	+$436K	﹤0.01%	3390

State Street's VTAE Position: Q4 2016 in Review

State Street sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 387,390 shares — an estimated $8.1M sold.

State Street first reported a position in VTAE in Q4 2014 and held it in 8 quarters. The position peaked at $8.1M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

State Street reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
State Street sold 387,390 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $8.1M.
State Street first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 8 quarters.
State Street's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $8.1M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on State Street's 13F filing for Q4 2016, filed 9 Feb 2017.